Industry Presentations

Metastatic Non-Small Cell Lung Cancer


Presentations

  • NON
    CME

    A First-Line Treatment for Metastatic Non-Small Cell Lung Cancer with Epithelial Growth Factor Receptor Exon 19 Deletion or Exon 21 L858R Substitution Mutations

    Speakers:Jesús Corral Jaime, MD

    Duration: 60 minutes

    Presented on: October 28, 2019

    *This session is not eligible for AMA PRA Category 1 CreditsTM